Table 4.
Hazards rate: survival
| Univariate Cox Regression | Multivariate Cox Regression | ||||
|---|---|---|---|---|---|
| HR (95% CI) | p-value | HR (95% CI) | p-value | ||
| Baseline Characteristics | |||||
| Age (years) | 1.01 (1.00-1.03) | 0.06 | 1.00 (0.98–1.02) | 0.8 | |
| BMI | 0.99 (0.95-1-03) | 0.6 | 1.03 (0.98–1.08) | 0.2 | |
| CCI | 1.17 (1.08–1.27) | 0.001 | 1.14 (1.05–1.24) | 0.002 | |
| Female Sex | 1.01 (0.69–1.45) | 1 | 0.94 (0.64–1.38) | 0.8 | |
| Primary Lung Tumours | 0.88 (0.57–1.37) | 0.6 | 0.87 (0.55–1.36) | 0.5 | |
| Preoperative ASA IV | 1.82 (1.23–2.63) | 0.002 | 1.33 (0.88-2.00) | 0.2 | |
| Current or Previous Smoker | 1.37 (0.87–2.15) | 0.2 | 1.49 (0.92–2.42) | 0.1 | |
| Respiratory Support Needed | 1.97 (1.34–2.88) | < 0.001 | 1.27 (0.81-2.00) | 0.3 | |
| Index Intervention | |||||
| Stent Insertion | 2.00 (1.35–2.94) | < 0.001 | 1.54 (1.03–2.33) | 0.03 | |
| Urgent or Semi-urgent | 2.08 (1.36–3.19) | < 0.001 | 1.30 (0.78–2.15) | 0.3 | |
| Level of Stenosis | |||||
| Tracheobronchial | 1.10 (0.59–2.06) | 0.8 | 1.47 (0.71–3.02) | 0.4 | |
| Unilateral bronchi | 0.83 (0.49–1.43) | 0.5 | 0.85 (0.48–1.51) | 0.6 | |
| Bilateral bronchi | 1.64 (0.78–3.42) | 0.2 | 2.93 (1.11–7.74) | 0.03 | |
| Oncological Treatment after Intervention | |||||
| Chemoradiotherapy | 0.76 (0.52–1.10) | 0.1 | 0.48 (0.32–0.72) | < 0.001 | |
| Immunotherapy | 0.47 (0.23–0.97) | 0.04 | 0.53 (0.25–1.10) | 0.09 | |
Multivariate HR: Adjusted for significant co-variables